Sanofi sees stand-alone Japan generics biz complementing JV

Save

Formulations of the two molecules, to be distributed by Sanofi's Japanese subsidiary, have already gained approval and will be launched in June at the time of the next general reimbursement price listing for generics. "Patients are looking for…